Struggling to Lose Weight With PCOS? How Mounjaro and Wegovy May Support Weight Loss

Struggling to Lose Weight With PCOS? How Mounjaro and Wegovy May Support Weight Loss.

If you have Polycystic Ovary Syndrome (PCOS) and feel that weight loss is significantly harder for you than for others, you are not alone — and it is not a failure of willpower.

Many women with PCOS follow calorie-controlled diets, exercise regularly, and still struggle to lose weight or maintain weight loss. This is due to the hormonal and metabolic features of PCOS, not lack of effort.

At Shape⁸, we take a medically led, UK-regulatory-compliant approach to weight management. This article explains why PCOS makes weight loss more difficult and how medications such as Mounjaro and Wegovy may support weight loss in clinically eligible individuals.

Why does PCOS make weight loss so difficult?

PCOS is a complex endocrine condition that commonly involves insulin resistance.
Insulin resistance means the body does not respond effectively to insulin, which can lead to:

• Increased fat storage, particularly around the abdomen
• Increased hunger and food cravings
• Blood sugar fluctuations
• Fatigue and low energy
• Reduced response to traditional calorie restriction

Because of this, women with PCOS often find that diet and exercise alone are less effective, even when followed carefully and consistently.

Why standard weight-loss advice often fails women with PCOS

Traditional weight-loss advice assumes normal insulin sensitivity and hormonal balance.

 In PCOS:

• The body may store fat more readily
• Hunger and satiety hormones may be dysregulated
• Weight loss may occur more slowly
• Weight regain is more common

For some women, this means lifestyle changes alone are not enough, and clinically supervised weight-loss support may be appropriate.

What are Mounjaro and Wegovy?

Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medications licensed in the UK for weight management in eligible adults following clinical assessment.

They belong to a class of medicines called GLP-1 receptor agonists, which act on appetite regulation and blood-sugar control pathways.

Mounjaro also acts on an additional hormone pathway involved in glucose regulation. 

How do Mounjaro and Wegovy work in the body?

These medications may support weight loss by:

• Reducing appetite and food cravings
• Slowing gastric emptying so you feel fuller for longer
• Supporting better blood-sugar regulation
• Improving insulin sensitivity

They do not replace healthy habits, but may support weight loss when used alongside dietary, behavioural, and lifestyle changes.

How may Mounjaro and Wegovy support weight loss in women with PCOS?

Mounjaro and Wegovy are not licensed to treat PCOS itself.

However, for women with PCOS who also meet clinical criteria for medical weight-loss treatment, they may help by addressing:

• Insulin resistance
• Appetite dysregulation
• Difficulty achieving or maintaining a calorie deficit 

 
For some women with PCOS, even modest weight loss can support improvements in metabolic health and PCOS-related symptoms.

Is weight loss clinically important in PCOS?

In many cases, yes.

Clinical guidance recognises that reducing excess body weight in women with PCOS may:

• Improve insulin sensitivity
• Reduce androgen levels
• Reduce inflammation
• Support menstrual regularity

Weight loss is not a cure for PCOS, but it can form part of a broader, medically supervised management plan.

Is Mounjaro or Wegovy better for PCOS?

There is no single best option.

The most appropriate treatment depends on:

BMI and medical eligibility
Individual metabolic profile
Previous response to weight-loss interventions
Tolerance of side effects
Clinician judgement following assessment

This decision should always be made following a clinician-led consultation.

Can these medications help with fertility in PCOS?

Mounjaro and Wegovy are not fertility treatments.

While weight loss and improved metabolic health may indirectly support hormonal balance in some women:

These medications must not be used during pregnancy
They are not suitable when actively trying to conceive
Fertility concerns should be discussed with an appropriate healthcare professional

Are Mounjaro and Wegovy safe for women with PCOS?

When prescribed appropriately and monitored in line with UK clinical standards, GLP-1 medications are considered safe for many individuals.

As with all prescription medicines, side effects can occur, most commonly:

Nausea
Gastrointestinal discomfort
Appetite changes

This is why treatment must always be clinically assessed, prescribed, and monitored.

Frequently Asked Questions: PCOS, Weight Loss, Mounjaro & Wegovy

Why is weight loss harder with PCOS?

PCOS often involves insulin resistance and hormonal imbalance, which can increase fat storage and appetite while reducing the body’s response to calorie restriction.

Can PCOS stop weight loss completely?

No, but it can slow weight loss significantly. Many women with PCOS require medical support to achieve sustainable results.

Do Mounjaro or Wegovy treat PCOS?

No. They are licensed for weight management, not for treating PCOS itself.

Can losing weight help manage PCOS?

Weight loss may improve metabolic health, insulin sensitivity, and hormonal regulation, but it is not a cure.

Is medical weight-loss treatment suitable for PCOS?

For some women who meet eligibility criteria, yes — when prescribed and monitored by a clinician.

How Shape⁸ supports women with PCOS and weight loss.

At Shape⁸, we recognise that PCOS-related weight struggles are medical — not motivational.

Our approach includes:

Clinician-led assessment and eligibility checks
Prescription-only treatment where appropriate
Ongoing clinical oversight
Support for sustainable lifestyle change
Transparent pricing
No subscriptions, no gimmicks, no pressure

All care is delivered in line with UK regulatory guidance.

Final thoughts:

PCOS changes how the body regulates weight. For some women, medical weight-loss treatments such as Mounjaro or Wegovy may offer appropriate support when lifestyle changes alone are not enough.

They are not a cure for PCOS, but they may help address one of its most challenging aspects — weight management when used under proper clinical supervision.

Concerned about PCOS and weight loss?

This content is for educational purposes only and does not replace medical advice. Prescription treatment is subject to clinical assessment, eligibility, and ongoing review.